Projects per year
Personal profile
Education
- 2010 Ph.D., Pharmaceutical Sciences, National Taiwan University
- 2001 B.S., School of Pharmacy, Taipei Medical University
Experience
- 2022- Full Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2022- Full Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2023-2024 Visiting Professor, Department of Pharmaceutical Chemistry, University of California San Francisco
- 2020-2022 Associate Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2018-2022 Associate Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2016-2017 Assistant Professor, Ph.D. Program in Drug Discovery and Development Industry, Taipei Medical University
- 2015-2018 Assistant Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2013-2015 Project Assistant Research Fellow, Department of Pharmaceutical Sciences, Taipei Medical University
- 2012-2013 Assistant Researcher, Department of Pharmaceutical Sciences, Taipei Medical University
Research Interests
- Computer-aided drug design.
- Development of kinase inhibitors and methyltransferase inhibitors against cancer cells.
- Developing new synthetic methodologies for bioactive molecules.
- Conducting modern synthetic methodologies, such as parallel synthesis and photochemistry.
- Total synthesis of natural products.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
優化與開發紡錘體檢查點抑制劑用於治療三陰性乳癌(3/3)
Lee, H.-Y. (PI)
8/1/26 → 7/31/27
Project: A - Government Institution › b - National Science and Technology Council
-
Optimization and Development of Spindle Assembly Checkpoint Inhibitors for the Treatment of Triple Negative Breast Cancer
Lee, H.-Y. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Optimization and Development of Spindle Assembly Checkpoint Inhibitors for the Treatment of Triple Negative Breast Cancer
Lee, H.-Y. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
開發高選擇性PLK2抑制劑並探討其對大腸直腸癌之功效與機轉
Lee, H.-Y. (PI)
7/1/23 → 2/29/24
Project: A - Government Institution › b - National Science and Technology Council
-
Development of Kinase Inhibitors with Pancreatic Cancer Inhibitory Activity
Lee, H.-Y. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Metformin Adherence and Risk of Polyneuropathy in Type 2 Diabetes Mellitus: An International Matched Cohort Study with Independent Validation
Tai, Y. H., Lee, H. Y., Huang, P. H., Chen, W. T., Chien, L. N., Chan, L. & Hong, C. T., Oct 2026, In: Metabolic Syndrome and Related Disorders. 24, 8, p. 353-362 10 p.Research output: Contribution to journal › Article › peer-review
-
Synthesis of 2-Aryl(alkyl)benzimidazole Hydroxamic Acids as HDAC Inhibitors with Anti-Angiogenesis Properties
Liu, Y. T., Lai, C. T., Wang, S. W., Liu, S. C., Hwang, Y. L., Tsai, Y. C., Lee, C. Y., Lai, Y. W., Yen, J. Y., Wang, P. C. & Lee, H. Y., Apr 28 2026, In: ChemMedChem. 21, 8, e202500984.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting epithelial-mesenchymal transition and apoptosis: novel histone methyltransferase inhibitors for colon cancer suppression
Lee, H. Y., Chang, C. H., Liu, Y. T., Landge, D. R., Chen, T. Y. & Cho, E. C., Apr 2026, In: Bioorganic and Medicinal Chemistry. 135, 118570.Research output: Contribution to journal › Article › peer-review
-
Discovery of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitors using an artificial intelligence model and their effects on tau and tubulin dynamics
Chen, J. H., Tu, H. J., Lin, T. E., Peng, Z. X., Wu, Y. W., Yen, S. C., Sung, T. Y., Hsieh, J. H., Lee, H. Y., Pan, S. L., HuangFu, W. C. & Hsu, K. C., Dec 2024, In: Biomedicine and Pharmacotherapy. 181, 117688.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Citations (Scopus) -
Enhancing anti-cancer capacity: Novel class I/II HDAC inhibitors modulate EMT, cell cycle, and apoptosis pathways
Lee, H. Y., Hsu, M. J., Chang, H. H., Chang, W. C., Huang, W. C. & Cho, E. C., Jul 15 2024, In: Bioorganic and Medicinal Chemistry. 109, 117792.Research output: Contribution to journal › Article › peer-review
11 Link opens in a new tab Citations (Scopus)
Datasets
-
Structure-guided design of anti-cancer ribonucleotide reductase inhibitors
Misko, T. A. (Contributor), Liu, Y.-T. (Contributor), Harris, M. E. (Contributor), Oleinick, N. L. (Contributor), Pink, J. (Contributor), Lee, H.-Y. (Contributor) & Dealwis, C. G. (Contributor), Unknown Publisher, Jan 1 2019
DOI: 10.6084/m9.figshare.7553114.v1, https://tandf.figshare.com/articles/Structure-guided_design_of_anti-cancer_ribonucleotide_reductase_inhibitors/7553114/1
Dataset
-
Effect of 3-subsitution of quinolinehydroxamic acids on selectivity of histone deacetylase isoforms
Lai, M.-J. (Creator), Lee, C.-H. (Creator), Chao, Y.-H. (Creator), Mehndiratta, S. (Creator), Chen, M.-C. (Creator), Liou, J.-P. (Creator) & Lee, H.-Y. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.13207104.v1, https://tandf.figshare.com/articles/journal_contribution/Effect_of_3-subsitution_of_quinolinehydroxamic_acids_on_selectivity_of_histone_deacetylase_isoforms/13207104/1
Dataset
-
Ring size changes in the development of class I HDAC inhibitors
Lee, H.-Y. (Contributor), Cho, E.-C. (Contributor), Tang, D.-W. (Contributor) & Liu, C.-Y. (Contributor), figshare Academic Research System, Jan 1 2021
DOI: 10.6084/m9.figshare.14843703.v1, https://tandf.figshare.com/articles/journal_contribution/Ring_size_changes_in_the_development_of_class_I_HDAC_inhibitors/14843703/1
Dataset
-
Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors
Lin, T. E. (Creator), Sung, L.-C. (Creator), Chao, M.-W. (Creator), Li, M. (Creator), Zheng, J.-H. (Creator), Sung, T.-Y. (Creator), Hsieh, J.-H. (Creator), Yang, C.-R. (Creator), Lee, H.-Y. (Creator), Cho, E.-C. (Creator) & Hsu, K.-C. (Creator), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.17162118.v1, https://tandf.figshare.com/articles/journal_contribution/Structure-based_virtual_screening_and_biological_evaluation_of_novel_small-molecule_BTK_inhibitors/17162118/1
Dataset